YD Bio Limited (YDES)

NASDAQ: YDES · Real-Time Price · USD

3.210

-0.660 (-17.05%)

Aug 28, 2026, 12:10 PM EDT - Market open

YD Bio Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	0.51	0.51	0.35	0.36
Revenue Growth	45.76%	45.76%	-3.84%	-
Gross Profit	0.16	0.16	0.15	0.13
Operating Income	-1.46	-1.46	-0.01	-0.04
Net Income	-1.41	-1.41	0.01	-0.05
Earnings Per Share	-1.29	-1.29	0.01	-
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	3.13	3.13	0.09	0.03
Total Debt	0.02	0.02	0.05	0.12
Net Cash (Debt)	3.11	3.11	0.04	-0.09
Net Cash Growth	7769.12%	7769.12%	-	-
Net Cash Per Share	2.84	2.84	0.04	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-1.84	-1.84	-0.06	0.07
Capital Expenditures	-0.07	-0.07	-0	-
Free Cash Flow	-1.91	-1.91	-0.06	0.07
Free Cash Flow Growth	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	30.44%	30.44%	43.82%	36.58%
Operating Margin	-286.45%	-286.45%	-2.81%	-12.33%
Pretax Margin	-271.67%	-271.67%	5.04%	-13.30%
Profit Margin	-276.58%	-276.58%	3.87%	-13.95%
FCF Margin	-374.58%	-374.58%	-15.98%	19.21%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	-	-	3497.13	-
P/FCF Ratio	-	-	-	720.26
PS Ratio	533.23	88.92	135.44	138.36